OKYO
Price
$3.12
Change
-$0.15 (-4.59%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
122.99M
23 days until earnings call
POLBF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Capitalization
23.91M
Interact to see
Advertisement

OKYO vs POLBF

Header iconOKYO vs POLBF Comparison
Open Charts OKYO vs POLBFBanner chart's image
OKYO Pharma
Price$3.12
Change-$0.15 (-4.59%)
Volume$1.78K
Capitalization122.99M
Poolbeg Pharma
Price$0.04
Change-$0.00 (-0.00%)
Volume$50K
Capitalization23.91M
OKYO vs POLBF Comparison Chart in %
Loading...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OKYO vs. POLBF commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OKYO is a Hold and POLBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (OKYO: $3.27 vs. POLBF: $0.04)
Brand notoriety: OKYO and POLBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OKYO: 55% vs. POLBF: 100%
Market capitalization -- OKYO: $122.99M vs. POLBF: $23.91M
OKYO [@Biotechnology] is valued at $122.99M. POLBF’s [@Biotechnology] market capitalization is $23.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OKYO’s FA Score shows that 0 FA rating(s) are green whilePOLBF’s FA Score has 1 green FA rating(s).

  • OKYO’s FA Score: 0 green, 5 red.
  • POLBF’s FA Score: 1 green, 4 red.
According to our system of comparison, POLBF is a better buy in the long-term than OKYO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OKYO’s TA Score shows that 3 TA indicator(s) are bullish while POLBF’s TA Score has 4 bullish TA indicator(s).

  • OKYO’s TA Score: 3 bullish, 3 bearish.
  • POLBF’s TA Score: 4 bullish, 0 bearish.
According to our system of comparison, POLBF is a better buy in the short-term than OKYO.

Price Growth

OKYO (@Biotechnology) experienced а +21.11% price change this week, while POLBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.40%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +19.43%.

Reported Earning Dates

OKYO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+22.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OKYO($123M) has a higher market cap than POLBF($23.9M). OKYO YTD gains are higher at: 184.373 vs. POLBF (-63.983).
OKYOPOLBFOKYO / POLBF
Capitalization123M23.9M515%
EBITDAN/AN/A-
Gain YTD184.373-63.983-288%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
OKYOPOLBF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
20%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
68%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
10%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
10%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BINP0.030.01
+56.32%
Bionoid Pharma Inc.
OTTW15.10N/A
N/A
Ottawa Bancorp, Inc.
PZCUY1.38N/A
N/A
PZ Cussons Plc.
STOSF5.01N/A
N/A
Santos Ltd.
VRBCF346.00N/A
N/A
Virbac SA

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+3.48%
XRTX - OKYO
28%
Poorly correlated
+2.58%
DYN - OKYO
28%
Poorly correlated
N/A
ACUT - OKYO
28%
Poorly correlated
+1.57%
NXTC - OKYO
28%
Poorly correlated
N/A
MRNA - OKYO
26%
Poorly correlated
-1.84%
More

POLBF and

Correlation & Price change

A.I.dvisor tells us that POLBF and VSTM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and VSTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
VSTM - POLBF
29%
Poorly correlated
+19.93%
NNVC - POLBF
24%
Poorly correlated
N/A
SNSE - POLBF
24%
Poorly correlated
+6.10%
ALXO - POLBF
20%
Poorly correlated
-3.97%
OKYO - POLBF
12%
Poorly correlated
+3.48%
More